VDAC1 and fatty liver disease: Coincidentally, sennoside A, which are the main components of sennosides, was reported to protect mitochondrial function and structure to improve hepatic steatosis by inhibiting the mitochondrial respiratory chain complex I and the voltage-dependent anion channel 1 (VDAC1) [47].